A high ratio of MPO-ANCA positivity to PR3-ANCA positivity and a high prevalence of ILD have been reported in Asian countries [8-10], and vice versa in northern European countries; ILD was reported in 7.2% of all patients with MPA in the United Kingdom and in less than 10% in other European countries [11,12]. The gene discussed is MPO; the disease is interstitial lung disease.